v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Stock Options Activity
A summary of the stock option activity under the Company’s equity incentive plans is presented below:
Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term		Aggregate
Intrinsic
Value
Balance as of December 31, 20256,000$2.85 7.98$— 
Granted— — — — 
Exercised— — — — 
Forfeited(54)2.78 — — 
Expired(271)3.21 — — 
Balance as of June 30, 20265,675$2.83 7.74$— 
Expected to vest at June 30, 20265,675$2.83 7.74$— 
Exercisable at June 30, 20263,825$3.14 7.68$— 
Schedule of RSU Activity
A summary of restricted stock unit (“RSU”) activity is presented below:
SharesWeighted Average Grant-
Date Fair Value
Outstanding as of December 31, 20253,170 $1.84 
Granted615 0.81 
Vested(1,874)1.48 
Forfeited(73)2.00 
Outstanding as of June 30, 20261,838 $1.86 
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense included in the condensed consolidated statements of operations:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Cost of revenue, excluding depreciation and amortization$328 $284 $680 $586 
Sales and marketing104 158 217 306 
General and administrative959 764 1,880 1,566 
Research and development159 120 325 245 
Total$1,550 $1,326 $3,102 $2,703